Wolverine Asset Management’s Tourmaline Bio TRML Stock Holding History

Wolverine Asset Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,120	Closed	-$580K	–	1870
2025 Q3	$580K	Buy	+12,120	New	+$336K	﹤0.01%	842

Wolverine Asset Management's TRML Position: Q4 2025 in Review

Wolverine Asset Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 12,120 shares — an estimated $580K sold.

Wolverine Asset Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $580K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Wolverine Asset Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Wolverine Asset Management sold 12,120 Tourmaline Bio shares in Q4 2025, an estimated $580K.
Wolverine Asset Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Wolverine Asset Management's Tourmaline Bio position peaked at $580K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.